Home
RLM NEWS

FDA relaxes chemical abortion rules to match desires of abortion providers

SUMMER 2016

On March 30 the Food and Drug Administration (FDA) altered its guidelines for using the drug Mifeprex (also known as mifepristone or RU-486) for an abortion. Mifeprex was first approved for abortions in 2000 and now approximately a quarter of abortions in the United States are done using Mifeprex.

The FDA’s previous guidelines called for the drug to be used in the first 49 days of pregnancy and for women to take three trips to the abortionist. The new guidelines extend the time the drug can be used to the first 70 days of pregnancy, reduce the number of visits to the abortionist to two and reduce the dosage.

The FDA’s previous web page on Mifeprex mentioned how several women had died from sepsis caused by the bacteria Clostridium sordellii after undergoing chemical abortions. The updated web page no longer has this important information on it.

The new guidelines also allow for non-physicians (such as physician assistants, nurse practitioners and midwives) to provide chemical abortions, dropping the physician requirement.

For years, abortion providers have been ignoring the FDA guidelines because giving women pills and sending them off to abort at home is less time-consuming and more profitable for the abortionist. In response to the actions of these abortionists, some states have passed legislation requiring abortionists to follow the FDA guidelines. Now the FDA has altered their guidelines to match how those abortionists have been using Mifeprex.


RETURN TO RLM NEWS HOME

© RIGHT TO LIFE OF MICHIGAN, 2340 PORTER ST SW, PO BOX 901, GRAND RAPIDS, MI 49509-0901, (616) 532-2300
PRIVACY POLICY | VIDEO/IMAGE USAGE POLICY